Tech Company Financing Transactions
Cardea Bio Funding Round
Cardea Bio secured a $6.5 million Series A financing round on 1/13/2021. Investors included 3E Bioventures and private investors.
Transaction Overview
Company Name
Announced On
1/13/2021
Transaction Type
Venture Equity
Amount
$6,500,000
Round
Series A
Investors
3E Bioventures (Lead Investor) (Karen Liu)
Proceeds Purpose
Proceeds from the financing will be used to further develop Cardea's proprietary Transistor platform, in order to significantly expand mass-manufacturing and further grow Cardea's number of commercial partnerships.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
8969 Kenamar Dr. 104
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
Cardea is the world's leading manufacturer and developer of breakthrough digital graphene biosensors that power the Internet of Biology. Cardea's mission is to transform the healthcare industry with innovative new capabilities that enable superior pharmaceutical development and monitoring, rapid onsite diagnostics, and cutting-edge life science research.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Heltzen
Chief Operating Officer
Janine Taylor
Chief Scientific Officer
Kiana Aran
Chief Technical Officer
Brett Goldsmith
VP - Bus. Development
Robert Lozuk
VP - Product Management
Ross Bundy
Browse more venture capital transactions:
Prev: 1/13/2021: Tessera Therapeutics venture capital transaction
Next: 1/13/2021: Descript venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs